10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 502,512 | 490,285 | 473,966 | 432,508 | 397,712 |
| Marketable Securities | 49,521 | 49,563 | 49,443 | 49,576 | 49,549 |
| Receivables | 50,629 | 56,137 | 82,493 | 96,592 | 119,067 |
| Inventories | 52,616 | 53,487 | 56,341 | 61,956 | 68,968 |
| TOTAL | $674,671 | $669,733 | $684,451 | $659,827 | $655,661 |
| Non-Current Assets | |||||
| PPE Net | 215,324 | 220,591 | 226,711 | 232,534 | 239,710 |
| Intangibles | 68,078 | 64,421 | 66,840 | 69,270 | 19,225 |
| Other Non-Current Assets | 71,993 | 61,014 | 63,363 | 65,730 | 65,374 |
| TOTAL | $355,395 | $346,026 | $356,914 | $367,534 | $324,309 |
| Total Assets | $1,030,066 | $1,015,759 | $1,041,365 | $1,027,361 | $979,970 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,694 | 17,425 | 12,733 | 18,069 | 15,938 |
| Accrued Expenses | 55,121 | 55,186 | 82,471 | 72,850 | 65,165 |
| Other current liabilities | 7,069 | 5,315 | 23,363 | 23,723 | N/A |
| TOTAL | $118,509 | $113,598 | $153,454 | $147,324 | $112,221 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,610 | 24,342 | 23,902 | 22,139 | 21,449 |
| Other Non-Current Liabilities | 76,328 | 77,699 | 81,084 | 84,046 | 83,200 |
| TOTAL | $86,011 | $87,837 | $91,585 | $94,917 | $94,470 |
| Total Liabilities | $204,520 | $201,435 | $245,039 | $242,241 | $206,691 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,291 | 126,956 | 127,752 | 126,553 | 124,490 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,541,992 | -1,524,061 | -1,510,591 | -1,494,339 | -1,466,867 |
| Other shareholders' equity | 77 | 114 | 225 | 138 | 220 |
| TOTAL | $825,546 | $814,324 | $796,326 | $785,120 | $773,279 |
| Total Liabilities And Equity | $1,030,066 | $1,015,759 | $1,041,365 | $1,027,361 | $979,970 |